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Abstract
Background: More than 12,000 simple sequence repeats (SSRs) have been identified in the
genome of Burkholderia mallei ATCC 23344. As a demonstrated mechanism of phase variation in
other pathogenic bacteria, these may function as mutable loci leading to altered protein expression
or structure variation. To determine if such alterations are occurring in vivo, the genomes of
various single-colony passaged B. mallei ATCC 23344 isolates, one from each source, were
sequenced from culture, a mouse, a horse, and two isolates from a single human patient, and the
sequence compared to the published B. mallei ATCC 23344 genome sequence.
Results: Forty-nine insertions and deletions (indels) were detected at SSRs in the five passaged
strains, a majority of which (67.3%) were located within noncoding areas, suggesting that such
regions are more tolerant of sequence alterations. Expression profiling of the two human passaged
isolates compared to the strain before passage revealed alterations in the mRNA levels of multiple
genes when grown in culture.
Conclusion: These data support the notion that genome variability upon passage is a feature of B.
mallei ATCC23344, and that within a host B. mallei generates a diverse population of clones that
accumulate genome sequence variation at SSR and other loci.
Background
Burkholderia mallei is a nonmotile, Gram-negative bacillus
and the causative agent of a severe disease known as glan-
ders. Humans are accidental hosts of B. mallei; the natural
hosts for B. mallei are horses, donkeys and mules [1-3].
There are two distinctive forms of glanders, the acute form
characterized by septicemia and pulmonary infection and
the chronic form characterized by suppurative infection
[4].
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a highly pathogenic clinical isolate [5,6], has been
recently published [7]. The genome of B. mallei ATCC
23344 contains more than 12,000 simple sequence
repeats (SSRs) within coding areas and in putative pro-
moter regions. It also contains numerous insertion
sequence elements. SSRs are repetitive DNA made of iden-
tical or mixed repeat units. SSRs have been known to be
highly polymorphic and to be distributed throughout the
genomes of eukaryotes [8,9]. The presence of prokaryotic
SSRs is well documented [10-14]. Studies using Saccharo-
myces cerevisiae and Escherichia coli as model organisms
have shown that the variability in these repeats may be
due to slipped-strand mispairing (SSM) during DNA rep-
lication [15] resulting in insertions or deletions (indels)
of repeat monomeric units [12,16]. These indel mutations
may destabilize an essential regulatory structure or ham-
per gene function or, if located within coding regions of
the gene, may cause frameshifts in the coding reading
frame or otherwise alter the amino acid sequence of the
protein product of the gene. SSRs have been used as mark-
ers for the identification of pathogenic bacteria and have
been implicated as an important prerequisite for bacterial
phase variation and adaptation [17-19].
Observations on glanders immunity make the presence of
such high levels of SSRs in the B. mallei genome particu-
larly intriguing. Immunity to glanders is not conferred by
a prior infection [4,23]. At present, there are no vaccines
that induce protective immunity in the horse or sterilizing
immunity in mice [6]. Serum from a glanderous horse
does not confer immunity on a recipient horse, and path-
ogenic strains have been reported to lose virulence on lab-
oratory passage and to regain it upon subsequent animal
passage [4]. A mechanism of reversible genome alteration
mediated possibly through SSRs mutations or insertion
sequence elements on passage could account for all of
these observations.
To the best of our knowledge, no studies reporting
genome sequence changes during short term acute infec-
tions have been reported for any bacterial pathogen. In
many human infections such as HIV, tuberculosis, lep-
rosy, and malaria, hosts and pathogens coexist for years or
decades. With the exception of HIV/AIDS, little is know
about the adaptation of the pathogen through genome
alterations during these chronic infection periods.
Genome sequence alterations have been explored in Pseu-
domonas aeruginosa in an opportunistic infection of a sin-
gle human cystic fibrosis patient by genome sequence
analysis of two single colony isolates at two times 8 years
apart [24]. Over this period 68 genome sequence altera-
tions were detected, 49 SNPS and 19 insertions/deletions.
Most insertions/deletions were 1 to 3 bases with no SSR
association noted.
Since B. mallei has been used previously as a biological
weapon [25,26], with potential for future use by terrorists,
studies on its mechanisms of pathogenesis and immunity
are of great importance. In this report, we explore the issue
of genome stability upon passage of B. mallei in culture
and in several mammalian hosts, including human. We
report that an unprecedented level of bacterial genome
alteration occurs in B. mallei upon short term passage.
While RNA viruses incur consequential rapid genome var-
iation as a major component of their strategy for escaping
the host immune response, the level of genome variation
reported here on B. mallei passage represents the first
report of such variation for a bacterial pathogen.
Results
SSRs within the B. mallei ATCC 23344 genome
The distribution of the 12,547 SSRs within the B. mallei
genome from an overview perspective appears to be ran-
dom: 2,997 (23.9%) are intergenic and 9,550 (76.1%) are
located within the coding regions of genes (Table 1). This
approximates the allocation of genomic DNA to the inter-
genic (14.4%) and coding fractions of the genome
(85.6%). In addition, when evaluating genes by func-
tional category, the distribution of genes containing SSRs
in each category reflects that in the genome. Heteropoly-
mer repeats (11,041) are more abundant than homopol-
ymer repeats (1,506). SSRs consisted of up to 111 tandem
copies of the repeat unit, which were found to be as long
as 14 nucleotides. The base composition of the SSR repeat
units is consistent with the base composition for the over-
all genome, 60 to 68% GC.
Indels within intergenic regions
After passage, a total of 33 indels were found within non-
coding or intergenic regions relative to the reference
genome sequence of B. mallei ATCC 23344: nine in the
laboratory culture passaged isolate, eight in the mouse
spleen isolate, eight in the horse lung isolate, three in the
human liver isolate, and five in the human blood isolate
Table 1: Perfect simple sequence repeats (SSRs) identified in the 
B. mallei ATCC 23344 genome.
Chromosome Coding Intergenic Total
5' end Middle 3' end
1 1809 1811 1786 1789 7195
2 1401 1433 1310 1208 5352
Total 3210 3244 3096 2997 12547
Locations of the SSRs in the genome are denoted with the 
coordinates of their start and end points (i.e. match 5' end and 3' end) 
in the relevant chromosomes (i.e. 1 or 2) and also with their relative 
positions within the coding region of a gene: 5' end, middle, and 3' 
end.Page 2 of 11
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ten indels were near or within a promoter sequence, and
twelve contained palindromic sequences. Such palindro-
mic structures have been shown to perform many impor-
tant biological roles including termination of
transcription. All indels identified, except for indels 6 in
the mouse spleen isolate and 8 in the lab culture and
indels 3 in the human liver isolate and 3 in the human
blood isolate, were different.
Intergenic indels within SSRs
Among the intergenic indels, those located within SSRs
are most common (24/33). The repetitive sequence units
differed from 7 to 14 nucleotides and each unit was
repeated from three to 111 times (Table 2). Eight of these
indels within SSRs were located close to promoter areas
and six were close to palindromic sequences.
Intergenic indels not within SSRs
A total of nine intergenic indels not located within repeti-
tive units were found (Table 2). All nine were near pro-
moter or palindromic regions.
Table 2: Indels within intergenic regions.
SSR Nearest ORF





Lab Culture 1 TTGCCCGGCGA 7 6 yes no BMA1136 Hypothetical protein
2 TTCGACGC 29 28 yes no BMA2062 Hypothetical protein
3 AGTCGGCA 38 39 no no BMA1136 Hypothetical protein
4 CGATTGCCCGG 7 8 yes no BMA1138 ABC transporter, putative
5 GGGGCTTC 9 8 no no BMA2063 Transcriptional regulator
6 TGCGCGA 19 15 no no BMA2374 THUMP domain protein
7 No (-G) NA NA yes no BMAA0389 Hypothetical protein
8 CTGTCGTG 21 22 no no BMAA0376 Transporter
9 GTGCGAT 19 20 no no BMAA1878 Transcriptional regulator
Mouse Spleen 1 GAGGCGT 26 25 no no BMA2774 Secretory path protein
2 No (+TT) NA NA yes no BMA1596 Acetyltransferase
3 CGCGAGG 23 22 yes no BMAA0247 Oxidoreductase
4 GTGGCGA 7 6 no no BMAA0375 Transcriptional regulator
5 AAGTTCCG 3 4 yes no BMAA0242 Acyl-CoA dehydrogenase
6 CTGTCGTG 21 22 no no BMAA0376 Transporter
7 TGGCGTT 26 27 yes no BMAA0242 Acyl-CoA dehydrogenase
8 GAAAGAGAC 10 11 yes no BMAA0815 DNA-binding regulator
Horse Lung 1 GTGAGCC 13 14 no no BMA0984 Hypothetical protein
2 No (-C) NA NA no yes BMAA1128 ABC Transporter
3 GGGAAACGCGAAAC 6 5 yes no BMAA1873 Hypothetical protein
4 No (-C) NA NA no yes BMAA1868 Aconitate hydratase
5 No (+C) NA NA no yes BMAA1420 Synthetase protein
6 No (+T) NA NA no yes BMAA1237 Carboxyvinyltransferase
7 GCGAAAC 5 6 no yes BMAA1872 Chemotaxis protein
8 GATGAGC 19 20 no yes BMAA0612 Signal sequence protein
Human Liver 1 GGCAAGTC 38 40 no yes BMA1135 Drug resistance 
transporter
2 No (-C) NA NA no yes BMAA1868 Aconitate hydratase
3 GTGCTGTC 21 22 no yes BMAA0375 Transcriptional regulator
Human Blood 1 TTGGCGC 111 109 no no BMAA1866 Conserved hypothetical 
protein
2 AAGCAGC 42 40 no yes BMAA0117 6-phosphofructokinase 
(pfk)
3 GTGCTGTC 21 22 no yes BMAA0375 Transcriptional regulator
4 No (-C) NA NA no yes BMAA1128 ABC transporter
5 No (-C) NA NA no yes BMAA1868 Aconitate hydratase
NA: Not applicable.Page 3 of 11
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Sixteen indels were found within coding regions of the
passaged isolates; four indels in the lab passaged isolate,
two indels in the mouse spleen isolate, three indels in the
horse lung isolate, four indels in the human liver isolate,
and three indels in the human blood isolate (Table 3).
Only seven indels are within SSRs, and 14 out of the 16
indels created a frameshift mutation within the encoded
protein. All indels identified except for two pairs, indels 1
and 2 from human blood and liver, and indel 3 from
human liver and blood, were different, suggesting that
there are numerous sites of elevated mutation in the B.
mallei genome that can potentially be altered in some
individuals in the bacterial population upon passage.
Coding region indels within SSRs
Only seven indels within repetitive sequence units differ-
ing from six to 12 nucleotides were found within coding
regions (Table 3). SSRs with a monomer length that is not
multiple of three and located within gene coding regions
can significantly alter the coding potential of a given tran-
script. Five of the seven indels within SSRs with unit
repeat of seven and eight nucleotides caused frameshift
mutations resulting in altered amino acids from the point
of mutation and premature truncation likely producing
an altered or non-functional protein. These five affected
proteins are annotated as either hypothetical or conserved
domain proteins. The other two SSR-containing indels
with unit repeat of six and 12 nucleotides only add two or
remove four amino acids from the encoded protein. One
of these proteins encodes a penicillin-binding protein,
PBP-1c, which normally functions in cell wall synthesis
and beta-lactam resistance.
Coding region indels not within SSRs
Most indels in coding regions (nine of 16) were not
located within SSRs (Table 3). These indels result from
uncorrected replication errors possibly reflecting a lower
level of DNA repair activity relative to other bacteria (see
Discussion).
Do in vivo accumulated indels alter gene expression 
patterns?
In order to determine if the genome sequence alterations
that accumulated during mammalian passage altered the
expression of the genes at the site of the indels, expression
profiling of the two human isolates (FMH and JHU) of B.
mallei was accomplished relative to the unpassaged paren-
tal strain (i.e. ATCC 23344) after growth in culture using
the whole genome glass slide amplicon array and proto-
cols previously described [7]. When the FMH and JHU
samples were each hybridized against the ATCC 23344
references, only a very limited number of genes showed
altered expression ratios of over 2 fold. For the FMH iso-
late only 59 genes were at a 2 fold or higher level more
while only two were at a 2 fold or more lower level (Table
4). For JHU the respective numbers were 17 and 3 (Table
5) with 13 of the up-regulated genes in common between
Table 3: Indels within coding regions.







Lab Culture 1 638 aa 29 aa (+C) No stop codonb BMAA1927 Hypothetical Protein
2 154 aa 50 aa (-T) 75 aa BMA1435 Hypothetical Protein
3 145 aa 64 aa (-G) 85 aa BMA2147 N utilization substance protein B
4 711 aa 586 aa (+A) No stop codonb BMA2914 Oxidoreductase
Mouse spleen 1a 942 aa No 938 aa BMAA0680 Penicillin-binding protein
2 357 aa 13 aa (+G) 321 aa BMA0161 Rod shape-determining protein MreC
Horse Lung 1 787 aa 525 aa (+G) 721 aa BMAA0367 Acetyltransferase, GNAT family
2a 136 aa No 138 aa BMAA0623 Hypothetical protein
3a 120 aa 66 aa 100 aa BMA2996 Hypothetical protein
Human Liver 1a 659 aa 52 aa 62 aa BMAA0729 Hypothetical protein
2a 122 aa 69 aa 85 aa BMA3028 Conserved domain protein
3 No translation 49 aa (+A) 361 aa BMAA1903 Conserved hypoth. protein
4 685 aa 164 aa (+T) 328 aa BMA0685 Vit. B12 receptor BtuB, putative
Human Blood 1a 122 aa 69 aa 85 aa BMA3028 Conserved domain protein
2a 193 aa 157 aa No stop codonb BMAA0789 Hypothetical protein
3 No translation 49 aa (+A) 361 aa BMA1903 Conserved hypoth. protein
aCoding region indels within SSRs. Mouse spleen 1a: repeat unit AACACCGAACCG; Horse lung 2a: repeat unit GGTGCC, 3a: repeat unit 
GAGCGGT; Human liver 1a : repeat unit CGAGTCAT extra copy in reference, 2a: repeat unit GCCGATT extra copy in query; Human blood 1a: 
GCCGATT extra copy in query, 2a: GCGCCTC two extra copies in reference.
bReference protein lost the stop codon at the original position due to the frameshift; query protein has a new stop codon in a different position.Page 4 of 11
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Table 4: Expression profile of unpassaged reference strain (ATCC 23344) relative to the human blood isolate (FMH), expressed as the 
log2 ratio of intensities.
Ratio Locus Annotation
2.15 BMAA0446 Rhs element Vgr protein
1.64 BMAA1895 conserved domain protein
1.60 BMAA0090 lipoprotein, putative
1.56 BMAA2014 hypothetical protein
1.52 BMAA1663 hypothetical protein
1.51 BMAA0618 hypothetical protein
1.49 BMAA0810 YadA-like C-terminal region protein
1.44 BMA2461 C4-dicarboxylate transport protein
1.43 BMAA2044 conserved hypothetical protein
1.42 BMA3164 hypothetical protein
1.42 BMA0632 conserved hypothetical protein
1.42 BMAA1384 hypothetical protein
1.41 BMAA1999 hypothetical protein
1.41 BMAA0682 hypothetical protein
1.39 BMA2875 hypothetical protein
1.38 BMAA1865 conserved hypothetical protein
1.38 BMAA0268 rubrerythrin
1.38 BMA1006 hypothetical protein
1.34 BMA0985 hypothetical protein
1.34 BMA0017 hypothetical protein
1.31 BMA0040 conserved hypothetical protein
1.31 BMAA0922 drug resistance transporter, EmrB/QacA family
1.30 BMA0813 conserved hypothetical protein
1.29 BMA0833 DNA-binding response regulator
1.28 BMA2979 acyltransferase family protein
1.28 BMAA0059 conserved hypothetical protein
1.26 BMAA0976 dipeptide ABC transporter, permease protein, putative
1.25 BMAA2019 hypothetical protein
1.25 BMAA1885 membrane protein, putative
1.24 BMA2676 DNA-binding response regulator
1.24 BMA1631 hypothetical protein
1.20 BMAA0737 Rhs element Vgr protein
1.20 BMA1854 Ser/Thr protein phosphatase family protein
1.19 BMA0859 hypothetical protein
1.18 BMA0036 hypothetical protein
1.14 BMAA1974 conserved hypothetical protein
1.13 BMAA0656 hypothetical protein
1.13 BMA1633 dioxygenase, TauD/TfdA
1.12 BMAA1879 hypothetical protein
1.11 BMAA0651 H-NS histone family protein
1.09 BMAA0585 secretory lipase family protein
1.09 BMAA0076 conserved domain protein
1.08 BMAA0178 hypothetical protein
1.08 BMAA0053 membrane protein, putative
1.07 BMAA0935 hypothetical protein
1.06 BMAA0204 ortho-halobenzoate 1,2-dioxygenase beta-ISP protein OhbA
1.06 BMAA1888 hypothetical protein
1.05 BMAA2035 stress response protein
1.05 BMA2983 ethanolamine ammonia-lyase heavy chain
1.05 BMAA1652 MoaC domain protein
1.04 BMA1132 hypothetical protein
1.04 BMAA1916 hypothetical protein
1.04 BMAA0112 hypothetical protein
1.04 BMAA1627 type III secretion inner membrane protein SctS
1.02 BMAA0391 monooxygenase family protein
1.01 BMAA0752 hypothetical protein
1.00 BMA3275 oxidoreductase, GMC family
1.00 BMAA0470 hypothetical protein
1.00 BMAA0061 RNA polymerase sigma-70 factor, ECF subfamily
-1.05 BMAA0866 hypothetical protein
-1.06 BMA1987 dTDP-4-dehydrorhamnose reductase
Genes exhibiting ≥ 2-fold intensity (mRNA abundance) difference are listed. Highlighted genes are also differentially expressed in the human liver 
isolate (JHU) (see Table 5).
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located very close to genes of the mutant site (Table 6A).
Genes co-located with the indel mutations in some cases
did show expression ratio alterations (Table 6B). To assess
the integrity of this data set, additional preparations of
RNA from the unpassaged ATCC 23344 strain were grown
and the RNA isolated on separate days. These two RNAs
were hybridized against each other. The results of this
hybridization showed no gene to be 2 fold up regulated in
either preparation relative to the other. In this experiment
approximately half (3156) of the genes showed RNA level
within 93% of each other (log2 of 0.10). In contrast for the
FMH vs. ATCC 23344 experiment only 1767 genes were
the same within this range and for the JHU vs. ATCC
23344 only 1634 genes were within this range. These data
suggest that the transcription profiles of the JHU and FMH
isolates when grown in culture are similar but modestly
distinct relative to each other and relative to the unpas-
saged ATCC 23344 strain.
Discussion
We have detected what appears to be a high level of
genome instability in B. mallei upon passage in culture or
in animals. Much of this instability is through alteration
in the number of repeat units within SSRs. If indeed these
SSRs function as sites for elevated levels of mutation on
passage, this affords tremendous potential for genome
variation within an animal host. With this potential in
mind, we sequenced B. mallei ATCC 23344 to various lev-
els of coverage after passage in culture and in mouse,
horse, and two isolates from an accidental infection of a
biodefense scientist [5].
We observed indel mutations both at SSR sites and other
locations with few or no SNPs resulting upon passage. In
Escherichia coli an increase in the rate of mutation under
stress conditions has been documented (reviewed in
[27]). The mutations are manifest as amplifications and
point mutations [28]. These mutations are mediated by
an error-prone DNA polymerase, DNA polymerase IV,
which is regulated by RpoS, the stress response sigma fac-
tor [29], the heat-shock chaperone GroES [29], and
polyphosphate kinase [30]. The B. mallei indels observed
upon passage could be the consequence of such a stress-
induced enhanced mutation rate upon host immune
response stress or upon that stress leading to reduced
growth rate upon entering stationary phase in culture.
That this may be true is suggested by the observation that
the B. mallei genome contains homologs of the E. coli pro-
teins demonstrated to participate in this process.
The mutations reported here upon passage of B. mallei are
indels at SSRs and other sites. Indels at SSRs that change
the number of repeat units are the result of slip-strand
mispairing during replication [15]; reviewed in [31]. Ele-
vated SSM rates at SSRs may be caused by an increased
likelihood of both slippage and misalignment [32,33].
Such replication errors are repaired by the mismatch
repair activities of the mutS, mutL, and mutM gene prod-
ucts. Indels in particular are a hallmark of reduced mis-
Table 5: Expression profile of the unpassaged reference strain (ATCC 23344) relative to the human liver isolate (JHU), expressed as 
the log2 ratio of intensities.
Ratio Locus Annotation
1.82 BMAA0090 lipoprotein, putative
1.81 BMA3047 heat shock protein, Hsp20 family
1.79 BMAA0446 Rhs element Vgr protein
1.68 BMA3048 heat shock protein, Hsp20 family
1.46 BMA2461 C4-dicarboxylate transport protein
1.24 BMA0118 RNA polymerase sigma factor RpoD, putative
1.22 BMAA0922 drug resistance transporter, EmrB/QacA family
1.19 BMAA0618 hypothetical protein
1.18 BMAA1865 conserved hypothetical protein
1.16 BMA2979 acyltransferase family protein
1.15 BMA0017 hypothetical protein
1.14 BMA3164 hypothetical protein
1.11 BMAA2014 hypothetical protein
1.06 BMAA1384 hypothetical protein
1.06 BMA2875 hypothetical protein
1.04 BMA0361 thioredoxin, authentic frameshift
1.01 BMA0859 hypothetical protein
-1.02 BMAA0427 TonB-dependent copper receptor
-1.04 BMA0665 phosphoadenosine phosphosulfate reductase, putative
-1.07 BMAA1196 transcriptional regulator, LysR family
Genes exhibiting ≥ 2-fold intensity (mRNA abundance) difference are listed. Loci in bold type are also differentially expressed in the human blood 
isolate (FMH) (see Table 4).Page 6 of 11
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to these mut genes, the role of these repair genes in the
generation of indels upon passage remains to be eluci-
dated.
The findings in this study also suggest that the genomic
distribution of SSR-associated indels is nonrandom across
coding and noncoding regions. SSR associated indels con-
stitute a large fraction of noncoding DNA indels and are
relatively rare in protein-coding regions. These SSRs
located in intergenic regions may affect gene transcription
and activity. It has been previously shown that important
regulatory sequence elements in viruses are often dupli-
cated within promoters, either directly repeated, or as
inverted copies of sequence segments [34]. Studies con-
ducted with geminivirus and nanovirus families of DNA
plant viruses revealed that DNA elements including those
containing small internal palindromic sequences play a
significant role in the enhancement of transcription and
contribute to regulation of in vivo viral gene expression
during plant infection [35]. It would not be surprising if
B. mallei uses a similar mechanism for regulation of gene
expression during in vivo infection.
Non-SSR associated indels in these passaged isolates
reflect the possible presence of reduced levels of replica-
tion associated DNA repair resulting in a large number of
indels on passage of B. mallei. This process of genome
alteration on passage is likely distinct from that leading to
SSR associated alterations.
The evolutionary history of B. mallei may be contributing
to its ability to tolerate this level of genome instability.
The B. mallei genome structure [7] demonstrates that B.
mallei is a reduced and rearranged version of B. pseudoma-
llei that has evolved from a versatile pathogenic soil
organism to an obligate mammalian parasite. This process
of reduction and rearrangement has been mediated
through the numerous IS elements present in the B. mallei
genome and has left multiple intact genes that are no
longer necessary to its life as a mammalian parasite. As an
example, it possesses a large set of mostly intact, relative
Table 6: Expression ratios of genes at or near sites of indels.
A. >2X UP REGULATED GENES NEAR INDELS
>2X Expression Altered Near Gene Intergenic Indels
BMAA1865 Human liver 2, BMAA1868
BMAA1865 Human blood 1, BMAA1866
BMAA1865 Human blood 5, BMAA1868
BMAA0112 FMH2, BMAA0117
B. EXPRESSION RATIOS OF INDEL GENES
Ratio Intergenic Indels
0.08 Human liver 1, BMA1135
0.29 Human liver 2, BMAA1868
0 Human liver 3, BMAA0375
0.47 Human blood 1, BMAA1866
-0.34 Human blood 2, BMAA0117
0.13 Human blood 3, BMAA0375
0.35 Human blood 4, BMAA1128
0.42 Human blood 5, BMAA1868
Indels within coding regions
0.62 Human liver 1, BMAA0729
0.63 Human liver 2, BMA0328
0.04 Human liver 3, BMAA1903
0.06 Human liver 4, BMA0685
0.93 Human blood 1, BMA3028
-0.15 Human blood 2, BMAA0789
0.48 Human blood 3, BMA1903Page 7 of 11
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is non-flagellated and non-motile. Such genes may pro-
vide a target for genome alterations, such as gene decay,
that would be under no selection.
In general, genome variation as an infection progresses is
a common strategy for pathogenesis employed by RNA
viruses to escape clearing by the host immune system.
Such large scale genome instability is not known to be a
regular feature of pathogenic bacteria. To the best of our
knowledge, no systematic study has been reported on the
stability of bacterial genomes upon passage in a mamma-
lian host during a short term acute infection. In Bacillus
anthracis, geographically distinct isolates differ in genome
sequence by only few SNPs [36], suggesting that the B.
anthracis genome would prove to be very stable upon pas-
sage. In contrast to B. mallei, there is little genome
sequence variation among the B. anthracis isolates
(reviewed in [37]). On a whole genome scale, much of the
increased rate of indels accumulated in B. mallei ATCC
23344 upon passage may simply be due to the large
number of these mutable SSR sites within the B. mallei
genome. The estimated rate of unrepaired DNA replica-
tion errors leading to SNPs in B. anthracis is approximately
10-10 changes per nucleotide per generation [38]. In B.
mallei, the rate of SNPs generated upon passage in the
human and the horse was observed to be very low.
For other bacteria, including B. mallei, the genome diver-
sity within the species includes major insertions and dele-
tions, eliminating the possibility of inferring anything
about genome stability upon passage based on the species
genome diversity. One of the SSR-containing indels that
we report here encodes penicillin-binding protein (PBP-
1c) that is usually involved in cell wall synthesis and beta-
lactam resistance. A study done by Jones et al. [39],
reported a novel function for a PBP-1a in group B strepto-
cocci. This study showed that this protein in vivo pro-
moted resistance to phagocytic killing independent of
capsular polysaccharide. It might be possible that within
the mouse the lack of one repeat unit and further loss of
four amino acids leads to a conformational change in this
membrane protein that allows for a novel function or
altered host immune response in vivo. If true, this could
be a mechanism used by B. mallei for evasion of immune
recognition and clearance in vivo.
One potential SNP was identified in the human blood iso-
late. This SNP, a C-G substitution, occurred in gene
BMAA0914, annotated as choline dehydrogenase. How-
ever, since we did not resequence the SNP its validity is
unconfirmed. We conclude from the SNP analysis that, in
contrast to our observation on the accumulation of indels,
SNPs are not generated to any consequential extent upon
passage. SNP analysis was not performed on the culture
and mouse isolates due to the 4X sequence coverage of
these isolates. This is sufficient coverage for indel analysis
because indels involve multiple base positions, and the
sequence quality across the region of the indels can be
used to ascertain the validity of the detected indels. Vali-
dating single base calls in a sequence requires more cover-
age so that SNP analysis was performed only for the two
human isolates sequenced to 9X coverage. Further studies
may include increasing the sequence coverage of the cul-
ture and mouse isolates in order to evaluate the SNPs in
these genomes.
The high sequence coverage of the horse passaged isolate
and of the two human isolates allows a calculation of the
level of genome variation upon passage in these hosts.
The altered bases in each instance, 53 of 5.8 Mb for the
horse isolate, 60 of 5.8 Mb for the human blood isolate,
and 42 of 5.8 Mb for the human liver isolate gives an aver-
age level of genome sequence alteration upon passage of
8.9 e-6. While this is less than what would be observed
upon passage of HIV, we postulate that it is at the very
high end of what would be observed upon passage of
other pathogenic bacteria. We further postulate that this
genome instability is a design feature of the structure and
replication machinery of the bacterium and is an integral
component of the organism's approach to survival within
the mammalian host.
The two isolates from the single human patient further
afford the opportunity to explore the B. mallei population
structure once it takes up residence in the mammalian
host and the level of sequential events of genome altera-
tion upon passage in the human host. The presence of
multiple indels, only two of which are common to the
two isolates, suggests that the organism is maintained not
as a clonal population once in the host but as a popula-
tion of variant individuals.
B. mallei genome sequence alterations accumulated and
fixed during the course of an infection in a mammalian or
human host would not be expected to reduce the fitness
of the individual bacterium within the host. If fitness of an
individual were reduced, it is expected that the individual
would be lost from the population. Thus, most alterations
of genome sequence that accumulate within a host would
be expected to have a minimum adverse consequence for
bacterial expression patterns within the host, while infre-
quently increasing fitness of the mutant individual.
Indeed, we have observed that those genes that are orthol-
ogous between B. mallei and B. pseudomallei were
expressed largely at identical levels within a mouse host
(Kim et al. unpublished), suggesting that expression pat-
terns within a host are well conserved in these Burkholderia
pathogens. The human isolates studied here when grown
in culture might be expected to exhibit some alteration inPage 8 of 11
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tions in the host. Indeed, a modest number of genes
exhibit modest alterations in levels of expression with sev-
eral of these genes near the sites of the indel mutations
(Table 4). All of the indels detected within coding regions
in the FMH and JHU isolates cause frameshifts, four in
JHU and three in FMH. These frameshifts, especially in
some of the regulatory genes, may account for the altered
in vitro patterns of expression reported here.
Conclusion
The inability of a mammalian host to gain immunity to
glanders infection, as well as its past and potential use as
a biological weapon, make understanding B. mallei path-
ogenicity, virulence, and mechanisms for evading the host
immune response of critical importance to the modern
world. We report here the occurrence of genome variation
in B. mallei ATCC 23344 upon its passage through several
mammalian hosts at a level unprecedented in bacteria. We
also report that two strains isolated from the infection of
a single human host exhibit distinct altered gene expres-
sion patterns relative to the unpassaged strain when
grown in culture. This genome instability upon passage
may have implications for vaccine development and treat-
ment of this very serious disease.
Methods
Bacterial isolates and DNA preparation
Laboratory passage
A glycerol stock of B. mallei ATCC 23344 was used to inoc-
ulate a petri plate containing Lennox LB agar (Sigma) with
4% glycerol (LBG). The plate was incubated at 37°C for 2
days and an inoculating loop was used to transfer cells
from the primary quadrant to a new LBG plate. The
remainder of the primary quadrant was harvested with a
sterile cotton swab, resuspended in LBG broth, mixed
with an equal volume of 40% glycerol, designated "labo-
ratory passage #1", and stored at -70°C. This process was
repeated, without interruption, a total of 23 times. Ten
microliters of "laboratory passage #23" was used to inoc-
ulate a LBG plate and isolated colonies were randomly
chosen after growth at 37°C for 2 days. One of the colo-
nies designated SLP 1 was grown in 3 ml of LBG broth
overnight at 37°C and genomic DNA was prepared fol-
lowing a previously described protocol [40]. SLP1 was
selected for subsequent sequencing.
Mouse passage
BALB/c mice were aerogenically infected with approxi-
mately 1 LD50 (1,000 cfu) of B. mallei ATCC 23344. An
infected mouse was sacrificed thirty-three days post-chal-
lenge and the spleen was removed, homogenized, serially
diluted in 0.85% NaCl, and cultured on LBG plates for 2–
3 days at 37°C. The spleen contained > 107 cfu/g, demon-
strating that the animal was acutely infected with B. mallei.
Isolated colonies were randomly selected and grown in 3
ml of LBG broth overnight at 37°C and genomic DNA was
prepared from each culture [40]. One designated CMI1
was selected for subsequent sequencing.
Horse passage
A single colony isolate of B. mallei was obtained from a
single horse from an experiment involving six horses used
in a study to characterize glanders disease progression
[41]. Animals were housed in biosafety level 3 contain-
ment at the National Centre for Foreign Animal Disease in
Winnipeg, Manitoba, where all experiments were per-
formed. Prior to the beginning of experimentation, ani-
mals were allowed to acclimatize to their surroundings for
a 2-week period. Horses were anesthetized and inoculated
intratracheally with 4 mL of a suspension containing 1 ×
1010 B. mallei ATCC 23344 cfu/mL [41]. Seven days fol-
lowing inoculation, horses were sacrificed, and lung sam-
ples were taken for B. mallei isolation. Approximately 5 g
of tissue were placed in 3 ml PBS in conical tubes. The tis-
sues were homogenized with a Brinkman Polytron
Homogenizer. Homogenates in PBS were plated on four
different media including BHI agar (Difco) containing 5%
sheep blood and 4% glycerol, Columbia CAN Agar
(Difco) containing 5% sheep blood, a selective trypticase
soy-based agar containing 1% glycerol, 1000 units poly-
myxin E, 1250 units bacitracin and 0.25 mg actidione per
100 ml [11], and MacConkey Agar (Difco). A single col-
ony isolate designated GB8 horse 4 was selected for
sequencing. Genomic DNA was prepared following a pre-
viously described protocol [40].
Isolates from a laboratory acquired infection
Two isolates were obtained from laboratory acquired
infection [5]. These B. mallei ATCC 23344 human isolates
were obtained from liver, designated JHU, and from
blood, designated FMH, approximately 2 months after
initial infection, and genomic DNA was prepared from
each culture [40].
All animals used in this research project were cared for
and used humanely according to the following policies:
The U.S. Public Health Service Policy on Humane Care
and Use of Animals (1996); the Guide for the Care and
Use of Laboratory Animals (1996); and the U.S. Govern-
ment Principles for Utilization and Care of Vertebrate Ani-
mals Used in Testing, Research, and Training (1985). All
NCI-Frederick animal facilities and the animal program
are accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International.
Shotgun sequencing and assembly
Shotgun sequencing was performed as described [7].
Sequence was accumulated to achieve 4X genome cover-
age for the culture and mouse isolates. Sequence was accu-Page 9 of 11
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isolate and 9X coverage of the two human isolates. These
genomes were assembled using the AMOScmp assembler
[42] with the B. mallei ATCC23344 genome sequence as
the assembly reference genome. This assembler uses a very
closely related genome sequence as a reference that is used
to guide the assembly of the shotgun sequence reads into
contigs.
Identification of SSRs and SNPs
A bioinformatics pipeline was developed consisting of
custom scripts that identify SNPs and indels when a shot-
gun genome assembly is compared to a closed reference
genome (B. mallei ATCC 23344). The scripts integrate the
whole genome alignment tool, MUMmer [43] to map
each contig to the reference genome sequence and identify
polymorphic sites. For each match, SNPs and indels are
extracted and automatically validated based on sequence
coverage and quality values of the region where the poly-
morphism is detected. Briefly, a SNP is considered of high
quality when its underlying sequence comprised at least
three sequencing reads with an average Phred score
[44,45] greater or equal to 30 on both the reference and
the query genome. Each sequence difference was further
reviewed and scored manually. When the indel report was
inconclusive, the underlying sequence traces and the con-
sensus sequence were analyzed using Cloe, the TIGR
sequence editor program, to correct scoring of the indel.
SNPs were identified and validated only for the two
human isolates since they were sequenced to high cover-
age. Indels were identified and validated for all of the iso-
lates.
Expression analysis
A whole genome PCR amplicon DNA microarray for B.
mallei were fabricated as previously described [7]. Total
RNA was isolated from in vitro cultures in LBG medium
of B. mallei ATCC 23344, FMH, and JHU. The OD600 of
the samples at harvest were all 0.55. The RNAs from FMH
and JHU were labeled and hybridized to the array using
the ATCC 23344 RNA as the reference using protocols as
described. Flip-dye replicates were performed for all anal-
yses. Two B. mallei ATCC 23344 samples grown to an
O.D.600 of 1.0 on separate days and total RNA was
extracted. These RNA samples were hybridized against
each other as a control for the JHU vs. ATCC 23344
hybridization and the FMH vs. ATCC 23344 hybridiza-
tion.
Microarray data availability
Microarray expression data presented in this manuscript
are available through ArrayExpress [Array Express at EBI:
[http://www.ebi.ac.uk/arrayexpress] with accession num-
bers A-MEXP-206 (array design) and E-MEXP-/// (experi-
mental data).
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